Amundi
PACB icon

Amundi’s Pacific Biosciences PACB Stock Holding History

Amundi’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,766
Closed -$12.8K – 2031
2025
Q1 		$12.8K Hold
10,766
– – ﹤0.01% 1875
2024
Q4 		$22.6K Buy
+10,766
New +$21K ﹤0.01% 1882
2024
Q2 		– Sell
-112,869
Closed -$165K – 2018
2024
Q1 		$165K Hold
112,869
– – ﹤0.01% 1678
2023
Q4 		$867K Sell
112,869
-47,086
-29% -$385K ﹤0.01% 1351
2023
Q3 		$1.28M Buy
159,955
+60,365
+61% +$690K ﹤0.01% 1265
2023
Q2 		$1.28M Buy
99,590
+99,226
+27,260% +$1.21M ﹤0.01% 1237
2023
Q1 		$3.99K Sell
364
-9,035
-96% -$89.8K ﹤0.01% 2020
2022
Q4 		$92.9K Sell
9,399
-8,704
-48% -$75K ﹤0.01% 1622
2022
Q3 		$118K Sell
18,103
-5
-0% -$29 ﹤0.01% 1529
2022
Q2 		$84K Buy
18,108
+17,725
+4,628% +$108K ﹤0.01% 1479
2022
Q1 		$3K Sell
383
-113,857
-100% -$1.31M ﹤0.01% 1627
2021
Q4 		$1.51M Sell
114,240
-152,141
-57% -$3.67M ﹤0.01% 1229
2021
Q3 		$6.81M Sell
266,381
-181,712
-41% -$5.38M ﹤0.01% 937
2021
Q2 		$15.7M Buy
+448,093
New +$13M 0.01% 736

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amundi's PACB Position: Q2 2025 in Review

Amundi sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 10,766 shares — an estimated $12.8K sold.

Amundi first reported a position in PACB in Q2 2021 and held it in 14 quarters. The position peaked at $15.7M in Q2 2021. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

  • Amundi reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 10,766 Pacific Biosciences shares in Q2 2025, an estimated $12.8K.
  • Amundi first reported a position in Pacific Biosciences in Q2 2021 and held it in 14 quarters.
  • Amundi's Pacific Biosciences position peaked at $15.7M in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.